Microarchitecture, the key to bone quality.

Bone has the ability to adapt its shape and size in response to mechanical loads via a process known as modelling in which bones are shaped or reshaped by the independent action of osteoblasts and osteoclasts. Remodelling is a process that maintains mechanical integrity of the skeleton, allowing it to selectively repair and replace damaged bone. During adulthood, bone remodelling is the dominant process; after the age of 40 years, the age-related decline in bone mass increases the risk of fracture, especially in women. Osteoporosis is defined as a reduction in bone mass and an impairment of bone architecture resulting in thinning and increased cortical porosity, bone fragility and fracture risk. As new products and methods have been developed, focusing on bone fragility, effective and sensitive non-invasive means able to detect early changes in bone fragility process have also been developed. Due to limitations in assessing fracture risk and response to therapy, the evaluation of bone mineral contents by bone densitometry is progressively replaced by new non-invasive and/or non-destructive techniques able to estimate bone strength, providing structural information about the pathophysiology of bone fragility by quantitative assessments of macro- and microstructural bone features. DXA and volumetric QCT quantify bone macrostructure, whereas high-resolution CT, microCT, high-resolution MR and microMR assess bone microstructure. Knowledge of bone microarchitecture is a clue for understanding osteoporosis pathophysiology and improving its diagnosis and treatment; the response of microarchitecture parameters to treatment should allow assessment of the real efficacy of the osteoporosis therapy.

[1]  R. Rizzoli,et al.  Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats , 2005, Osteoporosis International.

[2]  R. Rizzoli,et al.  The New Selective Estrogen Receptor Modulator MDL 103,323 Increases Bone Mineral Density and Bone Strength in Adult Ovariectomized Rats , 1999, Osteoporosis International.

[3]  H. Blair,et al.  Recent advances in osteoclast biology and pathological bone resorption. , 2004, Histology and histopathology.

[4]  S. Manolagas,et al.  Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. , 2000, Endocrine reviews.

[5]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[6]  L. Palermo,et al.  One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. , 2005, The New England journal of medicine.

[7]  Daniel Chappard,et al.  Trabecular bone microarchitecture: a review. , 2008, Morphologie : bulletin de l'Association des anatomistes.

[8]  Jessica D. Kaufman,et al.  Nanomechanical analysis of bone tissue engineering scaffolds. , 2007, Journal of biomedical materials research. Part A.

[9]  B. Clarke,et al.  Osteoporosis: Etiology, diagnosis, and management, 2nd ed Edited by B. Lawrence Riggs, M.D. and L. Joseph Melton, M.D., III. Philadelphia, Lippincott-Raven Publishers, 1995, $125.00 (xv + 542 pages), ISBN 0-7817-0275-5 , 1996, Trends in Endocrinology & Metabolism.

[10]  A. Hofman,et al.  Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. , 2004, Bone.

[11]  Y. Ubara,et al.  Histomorphometric features of bone in patients with primary and secondary hypoparathyroidism. , 2003, Kidney international.

[12]  Johan R de Jong,et al.  A comparison of micro-CT, microradiography and histomorphometry in bone research. , 2008, Archives of oral biology.

[13]  B. Troen Molecular mechanisms underlying osteoclast formation and activation , 2003, Experimental Gerontology.

[14]  B. Lawrence Riggs,et al.  Osteoporosis : etiology, diagnosis, and management , 1988 .

[15]  H Sievänen,et al.  Exercise-induced bone gain is due to enlargement in bone size without a change in volumetric bone density: a peripheral quantitative computed tomography study of the upper arms of male tennis players. , 2000, Bone.

[16]  E. Eriksen,et al.  Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. , 1986, Endocrine reviews.

[17]  G. Pharr,et al.  Elastic properties of human cortical and trabecular lamellar bone measured by nanoindentation. , 1997, Biomaterials.

[18]  S. Cummings,et al.  How drugs decrease fracture risk: lessons from trials. , 2002, Journal of musculoskeletal & neuronal interactions.

[19]  J. Shapter,et al.  Micromechanical properties of human trabecular bone: a hierarchical investigation using nanoindentation. , 2008, Journal of biomedical materials research. Part A.

[20]  Mary L Bouxsein,et al.  The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. , 2003, The New England journal of medicine.

[21]  H. K. Genant,et al.  Advanced CT bone imaging in osteoporosis , 2008, Rheumatology.

[22]  Mary L Bouxsein,et al.  Determinants of skeletal fragility. , 2005, Best practice & research. Clinical rheumatology.

[23]  R. Lindsay,et al.  Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts , 2005, Journal of cellular biochemistry.

[24]  S. Yamada,et al.  Menopause-related changes in bone mineral density in Japanese women: A longitudinal study on lumbar spine and proximal femur , 2004, Calcified Tissue International.

[25]  S. Goldstein,et al.  Elastic modulus and hardness of cortical and trabecular bone lamellae measured by nanoindentation in the human femur. , 1999, Journal of biomechanics.

[26]  M. Bouxsein Technology Insight: noninvasive assessment of bone strength in osteoporosis , 2008, Nature Clinical Practice Rheumatology.

[27]  G D Roodman,et al.  Cell biology of the osteoclast. , 1999, Experimental hematology.

[28]  F. Coe,et al.  Disorders of bone and mineral metabolism , 1992 .

[29]  K. Takaoka,et al.  Trabecular minimodeling in human iliac bone. , 2003, Bone.

[30]  Ego Seeman,et al.  Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. , 2004, Bone.

[31]  G. Cook,et al.  Primer on the metabolic bone diseases and disorders of mineral metabolism , 2003 .

[32]  D. Dempster,et al.  Anatomy and functions of the adult skeleton , 2006 .

[33]  Mathieu Charlebois,et al.  Validation of a voxel-based FE method for prediction of the uniaxial apparent modulus of human trabecular bone using macroscopic mechanical tests and nanoindentation. , 2007, Journal of biomechanics.

[34]  E. Barrett-Connor,et al.  Bone mineral density thresholds for pharmacological intervention to prevent fractures. , 2004, Archives of internal medicine.

[35]  P. Geusens,et al.  Relationship Between Changes in BMD and Nonvertebral Fracture Incidence Associated With Risedronate: Reduction in Risk of Nonvertebral Fracture Is Not Related to Change in BMD , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  S. Reddy Regulatory mechanisms operative in osteoclasts. , 2004, Critical reviews in eukaryotic gene expression.

[37]  P. Zysset,et al.  Morphological and Mechanical Properties of Bone Structural Units: A Two-Case Study , 2002 .

[38]  H. Genant,et al.  Advanced imaging of bone macrostructure and microstructure in bone fragility and fracture repair. , 2008, The Journal of bone and joint surgery. American volume.

[39]  H. Anderson Matrix vesicles and calcification , 2003, Current rheumatology reports.

[40]  R. Turner,et al.  Histological analysis of bone. , 2008, Methods in molecular biology.

[41]  Y. Ubara,et al.  Significance of minimodeling in dialysis patients with adynamic bone disease. , 2005, Kidney international.